trending Market Intelligence /marketintelligence/en/news-insights/trending/3c0m2fef8voe_avo0q-1zw2 content esgSubNav
In This List

G1 Therapeutics launches common stock offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


G1 Therapeutics launches common stock offering

Research Triangle Park, N.C.-based G1 Therapeutics Inc. is looking to raise money via the sale of 3 million shares of the company.

The news follows the biopharmaceutical company's earlier announcement about its medicine trilaciclib, which improved the immune system of patients undergoing chemotherapy for a type of lung cancer.

J.P. Morgan Securities LLC and Cowen and Co. LLC are the joint book-running managers for the offer. The underwriters have an option to buy an additional 450,000 shares.